To assess the role of p16 INK4A, bcl-2, and p53 in cervical cancer screening, we conducted a retrospective trial of prospectively collected data. Sixty two women with abnormal Pap smears were subjected to colposcopy and biopsies from any abnormal lesion. Human papillomavirus (HPV)-DNA typing, histology, and immunochemistry for p16INK4A, bcl-2, and p53 were performed for these women. Histologic diagnosis was that of low grade squamous intraepithelial lesion (LSIL), high grade squamous intraepithelial lesion (HSIL), or cancer in all cases. Human papillomavirus strains were identified in 56 patients (90.3%). All HSIL and invasive cancer cases were HPV positive. p16INK4A immunostaining yielded 100% sensitivity, 76% specificity, 61% positive predictive value, and 100% negative predictive value in cancer patients. The corresponding performance indicators for HSIL patients were 75%, 62%, 32%, and 91%. bcl-2 and p53 expression did not correlate with worsening grades of cervical disease. We conclude that p16INK4A seems to be a sensitive biomarker of high grade cervical intraepithelial neoplasia and cancer.
Sano T., Oyama T., Kashiwabara K., Fukuda T., Nakajima T.Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia . Pathol Int. 1998;48(8): 580-585.
2.
Klaes R., Benner A., Friedrich T., et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol. 2002;26(11):1389-1399.
3.
Katsumata M. , Siegel RM, Louie DC, et al. Differential effects of Bcl-2 on T and B cells in transgenic mice. Proc Natl Acad Sci U S A. 1992;89(23):11376-11380.
4.
Tjalma W., Weyler J., Goovaerts G., De Pooter C., Van Marck E., van Dam P.Prognostic value of bcl-2 expression in patients with operable carcinoma of the uterine cervix. J Clin Pathol. 1997;50(1):33-36.
5.
Crawford RA, Caldwell C., Iles RK, Lowe D., Shepherd JH, Chard T.Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer. Br J Cancer. 1998;78(2):210-214.
6.
Spitkovsky D. , Aengeneyndt F., Braspenning J., von Knebel Doeberitz M.p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Oncogene. 1996;13(5):1027-1035.
7.
Scheffner M.Ubiquitin, E6-AP, and their role in p53 inactivation . Pharmacol Ther. 1998;78(3):129-139.
8.
Zheng PS, Li SR, Iwasaka T., Song J., Cui MH, Sugimori H.Simultaneous detection by concensus multiplex PCR of high and low-risk and other types of human papilloma virus in clinical samples. Gynecol Oncol. 1995;58(2):179-183.
9.
Bernard HU, Chan SY, Manos MM, et al. Identification and assesment of known and novel human papillomavirus by polymerase chain reaction amplification, restriction fragment length polymorphism nucleotide sequence, and phylogenetic algorithms. J Infect Dis. 1994;170(5):1077-1085.
10.
Vernon SD, Unger ER, Williams S.Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol. 2000;38(2): 651-655.
11.
DeMay RMFailure of the Pap smear. In: The art & science of 3 cytopathology , Philip Rogers (Ed), Chicago: American Society for Clinical Pathology Press (ASCP Press); 1996:141-147.
12.
de Vet HC, Knipschild PG, Schouten HJ, et al. Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol. 1990;43(12):1395-1398.
13.
Robertson AJ , Anderson JM, Beck JS, et al. Observer variability in histopathological reporting of cervical biopsy specimens. J Clin Pathol. 1989;42(3):231-238.
14.
Dehn D., Torkko KC, Shroyer KRHuman papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer. 2007;111(1):1-14.
15.
Klaes R., Friedrich T., Spitkovsky D., et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92(2): 276-284.
16.
Murphy N., Ring M., Killalea AG, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol.2003;56(1): 56-63.
17.
Volgareva G., Zavalishina L., Andreeva Y., et al. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells. BMC Cancer. 2004;4:58.
18.
Guo M., Hu L., Baliga M., He Z., Hughson MDThe predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Am J Clin Pathol. 2004;122(6):894-901.
19.
Hu L., Guo M., He Z., Thornton J., McDaniel LS, Hughson MDHuman papillomavirus genotyping and p16INK4a expression in cervical intraepithelial neoplasia of adolescents. Mod Pathol. 2005 ;18(2):267-273.
20.
Qiao X., Bhuiya TA, Spitzer M. Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. J Low Genit Tract Dis. 2005;9(2):100-107.
21.
Lin ZH, Shen XH, Jin Z., et al. Human papillomavirus genotyping by oligonucleotide microarray and p16 expression in uterine cervical intraepithelial neoplasm and in invasive carcinoma in Korean women. Pathol Int. 2005 ;55(8):491-496.
22.
Lambert AP, Anschau F., Schmitt VMp16INK4A expression in cervical premalignant and malignant lesions. Exp Mol Pathol.2006;80(2):192-196.
23.
Queiroz C., Silva TC, Alves VA, et al. p16(INK4a) expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions. Pathol Res Pract.2006;202(2):77-83.
24.
Benevolo M. , Mottolese M., Marandino F., et al. Immunohistochemical expression of p16(INK4a) is predictive of HR-HPV infection in cervical low-grade lesions . Mod Pathol. 2006;19(3):384-391.
25.
Ishikawa M. , Fujii T., Saito M., et al. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia. Int J Gynecol Cancer. 2006;16(1):347-353.
26.
Eleutério J. Jr, Giraldo PC, Gonçalves AK, et al. Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus . Acta Obstet Gynecol Scand. 2007;86(1):94-98.
27.
Guedes AC, Brenna SM, Coelho SA, Martinez EZ, Syrjänen KJ, Zeferino LCp16(INK4a) Expression does not predict the outcome of cervical intraepithelial neoplasia grade 2. Int J Gynecol Cancer.2007 ;17(5):1099-1103.
28.
Focchi GR, Silva ID, Nogueira-de-Souza NC, Dobo C., Oshima CT, Stavale JNImmunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions. J Low Genit Tract Dis. 2007;11(2):98-104.
29.
Bahnassy AA , Zekri AR, Saleh M., Lotayef M., Moneir M., Shawki O.The possible role of cell cycle regulators in multistep process of HPV-associated cervical carcinoma. BMC Clin Pathol. 2007;7:4.
30.
Yildiz IZ, Usubütün A., Firat P., Ayhan A., Küçükali T.Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature. Pathol Res Pract. 2007;203(6): 445-449.
31.
Monsonego J. , Pollini G., Evrard MJ, et al. p16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear. Acta Cytol.2007;51(5):755-766.
32.
Liu H., Shi J., Wilkerson M., Huang Y., et al. Immunohistochemical detection of p16INK4a in liquid-based cytology specimens on cell block sections. Cancer. 2007;111(2):74-82.
33.
Feng W., Xiao J., Zhang Z., et al. Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma. Mod Pathol. 2007;20(9):961-966.
34.
El-Ghobashy AA, Shaaban AM, Innes J., Prime W., Herrington CSDifferential expression of cyclin-dependent kinase inhibitors and apoptosis-related proteins in endocervical lesions. Eur J Cancer. 2007;43(13):2011-2018.
35.
Milde-Langosch K., Albrecht K., Joram S., Schlechte H., Giessing M., Loning T.Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer. 1995;63(5):639-645.
36.
Avall-Lundqvist EH, Silfeverswand C., Aspenblad U., Nilsson BR, Auer GUThe impact of tumor angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma . Eur J Cancer. 1997;33(11):1799-1804.
